0000-0002-6828-1000 Synthetic biology research delivers interesting stories, some of which you can find on this blog and other outlets. The press coverage often revolves around the results and the potential applications. And the senior authors
0000-0002-6828-1000 Colin Scott is a Principal Research Scientist working at CSIRO, Canberra. He runs the CSIRO Biocatalysis and Synthetic Biology Team and he’s a Synthetic Biology Future Science Platform Domain Leader (Chemicals & Fibres).
0000-0002-6828-1000 If you submit you synthetic biology paper to Nature Communications, Ross Cloney is the person that will handle your case. After obtaining his PhD in Molecular Biology from the University of Sussex and two
Founded in 2004, Evolva is one of the first synthetic biology companies ever created, and it is a beautiful example of a successful business in our field. Evolva employs more than 175 people around the
The winning team of the overall iGEM Undergraduate Competition was from Heidelberg and consisted of twelve students and six advisors. Like the rest of their 2,000-plus colleagues, they were enthusiastic, thoughtful, well-spoken, and ready to